Kim JS, Flack KF, Malik V, Manichaikul A, Sakaue S, Luo Y, Anderson MR, Hoffman EA, Podolanczuk AJ, Yun J, McDermott G, Sparks JA, Moll M, Rich S, Rotter J, Noth I, Raghu G, Giles J, Winchester R, Raychaudhuri S, Hunninghake GM, Cho MH, Garcia CK, Barr RG, Bernstein EJ Genomic and Serological Rheumatoid Arthritis Biomarkers, MUC5B Promoter Variant, and Interstitial Lung Abnormalities , Ann Am Thorac So : 2024
Friedman Flack K, George M, Podolanczuk A, Kim J, Hoffman E, Johnson C, McGroder C, Smith B, Garcia C, Kreider M, Kawut S, Barr R.G, Anderson M, Bernstein E. Antinuclear antibodies and progression of high attenuation areas on chest computed tomography: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. , American Thoracic Society: 2023
Friedman Flack K & Katzen J. Revealing the rare: Pulmonary fibrosis from surfactant-related gene mutation. , CHEST., 163(4): 2023,744-745
Kim J, Flack K, Malik V, Manichaikul A, Sakaue S, Luo Y, Anderson M, Hoffman E, Podolanczuk A, Yun J, McDermott G, Sparks J, Moll M, Rich S, Rotter J, Noth I, Ragu G, Giles J, Winchester R, Raychaudhuri S, Hunninghake G, Cho M, Garcia C, Barr R.G, Bernstein E. Association of rheumatoid arthritis-related antibodies, HLA-DRB1, and MUC5B (rs35705950) with high attenuation areas, forced vital capacity, and interstitial lung abnormalities. , International Colloquium on Lung and Airway Fibrosis
: 2022
Friedman Flack, K., Gao, G.M., Berstein, E., Johnson, C., Diamond, J., Benvenuto, L. Arcasoy, S., Greeland, J., Betancourt, L., Oyster, M., Brown, M., Kalman, L., Zaleski, D., Adler, J., Tevald, M., Balar, P., Patel, S., Medikonda, N., Kreider, M., Christie, J., Singer, J., Anderson, M. Differences in body composition and frailty between lung transplant candidates with connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis. , American Thoracic Society: 2022
Friedman Flack K, Grimm J, Haas A, Jarrar D, Szeto W, Palevsky H. Massive hemoptysis secondary to an aortomediastinoparenchymal fistula. , American Thoracic Society International Conference. : 2020
Friedman Flack K, Chu S, Ciunci C, Berman A, Kreider M, Porteous M. The management and outcomes of patients with both interstitial lung disease and lung cancer. , American Thoracic Society International Conference. Dallas, TX: 2019
Kolb JM*, Friedman Flack K*, Chatterjee-Murphy P, Desai J, Wallentin L, Ezekowitz M, Connolly S, Reilly P, Brueckmann M, Ilgenfritz J, Aisenberg J., *co-first authors Locations and mucosal lesions responsible for major gastrointestinal bleeding in patients on warfarin or dabigatran. , Dig Dis Sci. , 63(7): 2018,1878-1889
Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, Weitz J, Ruff C, Nordio F, Mercuri M, Choi Y, Antman E, Braunwald E, Giugliano R. Gastrointestinal bleeding with edoxaban versus warfarin: Results from the ENGAGE AF- TIMI 48 trial. , Circ Cardiovasc Qual Outcomes, 11(5): 2018,epub
Romanoff A, Schmidt H, McMurray M, Weltz C, Schwartzman M, Friedman K, Margolies L, Port E. Who is ordering MRIs in newly diagnosed breast cancer patients? , Am Surg. , 84(3): 2018,351-357
